Your browser doesn't support javascript.
loading
Recent advances in bioprinting using silk protein-based bioinks.
Chakraborty, Juhi; Mu, Xuan; Pramanick, Ankita; Kaplan, David L; Ghosh, Sourabh.
Afiliação
  • Chakraborty J; Department of Textile and Fibre Engineering, Indian Institute of Technology Delhi, New Delhi-110016, India.
  • Mu X; Department of Biomedical Engineering, Tufts University, Medford, MA, 2155, USA.
  • Pramanick A; Department of Textile and Fibre Engineering, Indian Institute of Technology Delhi, New Delhi-110016, India.
  • Kaplan DL; Department of Biomedical Engineering, Tufts University, Medford, MA, 2155, USA.
  • Ghosh S; Department of Textile and Fibre Engineering, Indian Institute of Technology Delhi, New Delhi-110016, India. Electronic address: Sourabh.Ghosh@textile.iitd.ac.in.
Biomaterials ; 287: 121672, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35835001
3D printing has experienced swift growth for biological applications in the field of regenerative medicine and tissue engineering. Essential features of bioprinting include determining the appropriate bioink, printing speed mechanics, and print resolution while also maintaining cytocompatibility. However, the scarcity of bioinks that provide printing and print properties and cell support remains a limitation. Silk Fibroin (SF) displays exceptional features and versatility for inks and shows the potential to print complex structures with tunable mechanical properties, degradation rates, and cytocompatibility. Here we summarize recent advances and needs with the use of SF protein from Bombyx mori silkworm as a bioink, including crosslinking methods for extrusion bioprinting using SF and the maintenance of cell viability during and post bioprinting. Additionally, we discuss how encapsulated cells within these SF-based 3D bioprinted constructs are differentiated into various lineages such as skin, cartilage, and bone to expedite tissue regeneration. We then shift the focus towards SF-based 3D printing applications, including magnetically decorated hydrogels, in situ bioprinting, and a next-generation 4D bioprinting approach. Future perspectives on improvements in printing strategies and the use of multicomponent bioinks to improve print fidelity are also discussed.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article